Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.